Decibel Therapeutics Inc

NASDAQ:DBTX  
7.18
-0.22 (-2.97%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Decibel Therapeutics Inc Stock, NASDAQ:DBTX

1325 Boylston Street, Suite 500, Boston, Massachusetts 02215
United States of America
Phone: +1.617.370.8701
Number of Employees:

Description

Decibel Therapeutics, Inc. discovers and develops medicines to protect, repair, and restore hearing. The firm focuses on hearing disorders, including noise-induced hearing loss; residual hearing preservation or improved sound fidelity with cochlear implants; presbycusis or age-related hearing loss; tinnitus, a persistent ringing in the ears; and genetic hearing loss. It also offers drugs for pediatric cancer and cystic fibrosis patients who experience ototoxicity or hearing loss. The company was founded by Kevin Paul Starr, M. Charles Liberman, Gabriel Corfas, Ulrich M??ller, and Albert Edge in October 2015 and is headquartered in Boston, MA.